Information Provided By:
Fly News Breaks for March 20, 2019
ZTS
Mar 20, 2019 | 06:43 EDT
UBS analyst Navin Jacob resumed coverage of Zoetis with a Neutral rating, also raising his price target to $100 from $86. The analyst says the company is executing well following its most recent "solid quarter", and that the management's color on its Simparica Trio and new Dermatology product for cats has led him to boost his longer term companion animal pipeline revenue outlook by $40M by 2025. In the near term, the analyst sees Zoetis shares as "fairly valued".
News For ZTS From the Last 2 Days
There are no results for your query ZTS